Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Articles
Family History of Cancer/Genetic Counseling Often Lacking for Patients First Presenting with Malignancy
Read More
For Advanced GIST, Regorafenib Shows Robust Effect
Read More
Cancer Screening Is Cost-Effective, Saves Lives
Read More
Cancer Therapies in Short Supply Prompt a Response at the Federal Level
Read More
High OOP Costs for Medicare Patients with Cancer
Read More
The Cost of Lung Cancer at the End of Life: Early Institution of Palliative Care Improves Survival
Read More
Why Hasn’t Genomic Testing Changed the Landscape?
Read More
Radiotherapy-Related Hospital Admissions Are Frequent
Read More
Metastatic Colorectal Cancer: Prolonged Bevacizumab Improves Outcomes, New Targeted Therapies on the Horizon
Read More
Patients Willing to Pay for Genetic Testing to Assess Cancer Risk
Read More
196
197
198
199
200
201
202
Page 199 of 244
Results 1981 - 1990 of 2434